Page last updated: 2024-08-21

3',5'-dichloromethotrexate and Cancer of Liver

3',5'-dichloromethotrexate has been researched along with Cancer of Liver in 6 studies

Research

Studies (6)

Timeframe	Studies, this research(%)	All Research%
pre-1990	6 (100.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
ADAMSON, RH; LOO, TL; MORRIS, HP	1
Bahendeka, S; Katongole-Mbidde, E; Kyalwazi, SK; Mugerwa, J; Olweny, CL; Otim, D	1
Donehower, RC; Eddy, JL; Ihde, DC; Myers, CE; Tester, WJ	1
Friedman, MA	1
Eddy, JL; Ihde, DC; Makuch, RW; Matthews, MJ; McIntire, KR; Seeff, LB	1
Beschorner, J; Cooper, RM; DuBrow, RA; Faintuch, J; Hagle, M; Karl, RC; Levin, B; Shepard, KV; Stablein, D	1

Reviews

1 review(s) available for 3',5'-dichloromethotrexate and Cancer of Liver

Article	Year
Hepatic intraarterial chemotherapy--current status and future prospects--"If you have a short sword, take a step forward". Gan to kagaku ryoho. Cancer & chemotherapy, 1983, Volume: 10, Issue:5 Topics: Carcinoma, Hepatocellular; Catheterization; Colonic Neoplasms; Doxorubicin; Floxuridine; Hepatic Artery; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Methotrexate; Rectal Neoplasms	1983

Other Studies

5 other study(ies) available for 3',5'-dichloromethotrexate and Cancer of Liver

Article	Year
Metabolism of C136-dichloromethotrexate by transplantable liver tumors. Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.), 1962, Volume: 111 Topics: Carcinoma, Hepatocellular; Folic Acid Antagonists; Liver; Liver Neoplasms; Methotrexate	1962
Further experience in treating patients with hepatocellular carcinoma in Uganda. Cancer, 1980, Dec-15, Volume: 46, Issue:12 Topics: Adolescent; Adult; Aged; alpha-Fetoproteins; Azacitidine; Carcinoma, Hepatocellular; Child; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Female; Hepatic Artery; Humans; Injections, Intravenous; Ligation; Liver Neoplasms; Male; Methotrexate; Middle Aged; Pigmentation Disorders; Razoxane; Uganda	1980
Evaluation of weekly escalating doses of dichloromethotrexate in patients with hepatocellular carcinoma and other solid tumors. Cancer chemotherapy and pharmacology, 1982, Volume: 8, Issue:3 Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Carcinoma, Hepatocellular; Drug Administration Schedule; Female; Humans; Liver Neoplasms; Male; Methotrexate; Middle Aged; Protein Binding; Serum Albumin	1982
Prognostic factors in patients with hepatocellular carcinoma receiving systemic chemotherapy. Identification of two groups of patients with prospects for prolonged survival. The American journal of medicine, 1985, Volume: 78, Issue:3 Topics: Adolescent; Adult; Aged; alpha-Fetoproteins; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Doxorubicin; Female; Follow-Up Studies; Humans; Liver Neoplasms; Male; Methotrexate; Middle Aged; Prognosis; Streptozocin; Time Factors	1985
Therapy for metastatic colorectal cancer with hepatic artery infusion chemotherapy using a subcutaneous implanted pump. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1985, Volume: 3, Issue:2 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemical and Drug Induced Liver Injury; Colonic Neoplasms; Drug Administration Schedule; Female; Floxuridine; Hepatic Artery; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Male; Methotrexate; Middle Aged; Mitomycins; Peptic Ulcer; Prostheses and Implants; Rectal Neoplasms	1985